As of 2026-04-02, 泰圣奇's data on the DeepSeek platform in the 医药行业 category shows: The overall mention rate is 2.04%, above the industry average by 0.4 percentage points, showing notable performance. The first mention rate is only 0.00%, it is recommended to enhance first-position exposure in AI model responses. Negative mention rate (0.00%) has exceeded positive (0.00%), it is recommended to immediately initiate reputation repair. Among 6 competitors in the same category, 泰圣奇's overall mention rate surpasses 4 brands. AIGeo recommends combining the above data to formulate targeted brand monitoring strategies to further enhance brand visibility and reputation in the AI search ecosystem.
泰圣奇's Mention Rate is 2.04%, lower than 0.6% of competitors
泰圣奇's First Mention is 0.00%, lower than 0.9% of competitors
泰圣奇's Preferred Rate is 0.00%, lower than 100.0% of competitors
泰圣奇's Positive Rate is 0.00%, lower than 8.9% of competitors
泰圣奇's Negative Rate is 0.00%, higher than 96.3% of competitors
| Competitor | Mention Rate | First Mention | Preferred Rate | Positive Rate | Negative Rate | Actions |
|---|---|---|---|---|---|---|
| 赫赫赛汀 | 6.12% | 0% | 0% | 0% | 0% | View Details |
| HHPV疫苗 | 2.04% | 0% | 0% | 0% | 0% | View Details |
| 泰泰圣奇 (Current Brand) | 2.04% | 0% | 0% | 0% | 0% | View Details |
| KKeytruda | 0% | 0% | 0% | 0% | 0% | View Details |
| 格格列卫 | 0% | 0% | 0% | 0% | 0% | View Details |
| mmRNA新冠疫苗 | 0% | 0% | 0% | 0% | 0% | View Details |
| 安安维汀 | 0% | 0% | 0% | 0% | 0% | View Details |
